Evaluation of Electrolyte Imbalances and Their Impact on Mortality in Percutaneous Endoscopic Gastrostomy Patients in the Emergency Department

Year 2025, Volume: 52 Issue: 4, 659 - 670, 12.12.2025

Ali Sarıdaş , Naile Fevziye Mısırlıoglu Nedim Uzun Türker Acehan , Sumeyye Nur Aydin Aysun Ekinci , Hafize Uzun

https://doi.org/10.5798/dicletip.1840507

Abstract

Introduction: Percutaneous endoscopic gastrostomy (PEG) is a nutritional intervention used in patients with impaired oral intake but a functioning gastrointestinal system. PEG is considered the gold standard access route for long-term enteral nutrition. This study aims to evaluate the changes in serum electrolyte levels in patients with PEG presenting to the Emergency Department (ED) and to investigate their association with clinical outcomes, including morbidity and mortality.
Methods: In this single-center retrospective cohort study, 87 patients with PEG admitted to the ED between January 1, 2021, and January 1, 2025, were analyzed.
Results: The mean age was 70.2 ± 6.8 years, and 36.8% were female. The most common admission reason was tube obstruction/leakage (48.3%). Electrolyte disturbances were detected in 21.8% of patients. The overall mortality rate was 9.2%, with all deceased patients exhibiting electrolyte abnormalities(p<0.001). Hypochloremia, hypophosphatemia, and elevated bicarbonate levels were significantly associated with mortality (p<0.001 for all). Normal calcium and potassium levels correlated with increased survival (p<0.001; p=0.001, respectively). Elevated inflammatory markers (LDH, WBC, CRP) were significantly higher in non-survivors (p<0.05). Logistic regression identified increased bicarbonate level as an independent risk factor for mortality (OR 1.36; 95% CI 1.08–1.72; p=0.01). No significant associations were found between electrolyte levels and morbidity, except higher magnesium and inflammatory markers in patients with neurological or infectious complications. Conclusion: Electrolyte disturbances, particularly hypochloremia, hypophosphatemia, and elevated bicarbonate, are strongly associated with mortality in PEG patients presenting to the ED. Close monitoring and correction of electrolytes may improve outcomes in this vulnerable population

Keywords

Bicarbonate , Electrolyte Disturbance , Emergency Department , Mortality , Percutaneous Endoscopic Gastrostomy (PEG)

Acil Serviste Perkütan Endoskopik Gastrostomi Uygulanan Hastalarda Elektrolit Dengesizliklerinin Değerlendirilmesi ve Mortalite Üzerindeki Etkileri

Abstract

Giriş: Perkütan endoskopik gastrostomi (PEG), oral alımı bozulmuş ancak gastrointestinal sistemi işlevsel olan hastalarda uygulanan bir beslenme yöntemidir. PEG, uzun dönem enteral beslenme için altın standart giriş yolu olarak kabul edilmektedir. Bu çalışmanın amacı, PEG taşıyan ve acil servise (AS) başvuran hastalarda serum elektrolit düzeylerindeki değişiklikleri değerlendirmek ve bu değişikliklerin morbidite ve mortalite gibi klinik sonuçlarla olan ilişkisini araştırmaktır.
Yöntemler: Bu tek merkezli, retrospektif kohort çalışmasında, 1 Ocak 2021 ile 1 Ocak 2025 tarihleri arasında AS’ye başvuran PEG'li 87 hasta analiz edilmiştir.
Bulgular: Hastaların ortalama yaşı 70,2 ± 6,8 yıl olup, %36,8’i kadındı. En sık başvuru nedeni PEG tüpü tıkanıklığı/sızıntısıydı (%48,3). Hastaların %21,8’inde elektrolit bozuklukları tespit edildi. Genel mortalite oranı %9,2 olup, hayatını kaybeden tüm hastalarda elektrolit bozukluğu mevcuttu (p<0,001). Hipokloremi, hipofosfatemi ve yüksek bikarbonat düzeyleri mortalite ile anlamlı düzeyde ilişkiliydi (tümünde p<0,001). Normal kalsiyum ve potasyum düzeyleri, sağkalım ile pozitif yönde ilişkiliydi (sırasıyla p<0,001 ve p=0,001). Artmış inflamatuar belirteçler (LDH, lökosit, CRP, CRP/albumin oranı) yaşamını yitiren hastalarda anlamlı olarak daha yüksekti (p<0,05). Lojistik regresyon analizinde artmış bikarbonat düzeyi, mortalite için bağımsız risk faktörü olarak saptandı (OR: 1,36; %95 GA: 1,08–1,72; p=0,01). Elektrolit düzeyleri ile morbidite arasında anlamlı ilişki bulunmazken, nörolojik veya enfeksiyöz komplikasyonları olan hastalarda magnezyum düzeyleri ve inflamatuar belirteçlerin daha yüksek olduğu görüldü.
Sonuç: Acil servise başvuran PEG hastalarında görülen elektrolit bozuklukları, özellikle hipokloremi, hipofosfatemi ve yüksek bikarbonat düzeyleri, mortalite ile güçlü şekilde ilişkilidir. Bu kırılgan hasta grubunda elektrolitlerin yakından izlenmesi ve zamanında düzeltilmesi, klinik sonuçları iyileştirebilir.

Keywords

Bikarbonat , Elektrolit Bozukluğu , Acil Servis , Mortalite , Perkütan Endoskopik Gastrostomi (PEG).

References

• 1.Bischoff SC, Austin P, Boeykens K, et al. ESPENguideline on home enteral nutrition. Clin Nutr. 2020; 39: 5-22.
• 2.Strahm R, Weber M, Wiest R, Schmitt KU. EarlyTube Feeding after Percutaneous EndoscopicGastrostomy (PEG): An Observational Study.Nutrients. 2023; 15: 1157.
• 3.Boylan C, Barrett D, Li V, Merrick S, Steed H.Longitudinal complications associated with PEG:Rate and severity of 30-day and 1-yearcomplications experienced by patients after primary PEG insertion. Clin. Nutr. ESPEN. 2021; 43: 514–21.
• 4.Bilgiç NM, Kahveci G, Özşenel EB, Basat S. One-Year Mortality After Percutaneous EndoscopicGastrostomy: The Prognostic Role of NutritionalBiomarkers and Care Settings. Nutrients. 2025; 17:904.
• 5.Tae CH, Lee JY, Joo MK, et al. Clinical practiceguidelines for percutaneous endoscopicgastrostomy. Clin Endosc. 2023; 56: 391-408.
• 6.Brown L, Oswal M, Samra AD, et al. Mortality andInstitutionalization After Percutaneous EndoscopicGastrostomy in Parkinson’s Disease and RelatedConditions. Mov. Disord. Clin. Pract. 2020; 7: 509–15.
• 7.Sundbom M, Cabrera E, Nyman R, et al. Arandomized trial comparing percutaneousendoscopic gastrostomy (PEG) and radiologicallyinserted percutaneous gastrostomy (RIG). Scand JSurg 2023; 112: 69e76.
• 8.Grant DG, Bradley PT, Pothier DD, et al.Complications following gastrostomy tube insertionin patients with head and neck cancer: a prospectivemultiinstitution study, systematic review and meta-analysis. Clin Otolaryngol. 2009; 34: 103-12.
• 9.Vieira J, Nunes G, Santos CA, Fonseca J. Serumelectrolytes and outcome ın patıents undergoıngendoscopıc gastrostomy. Arq Gastroenterol. 2018;55: 41-5.
• 10.Gauderer MW, Ponsky JL, Izant RJ Jr.Gastrostomy without laparotomy: a percutaneousendoscopic technique. J Pediatr Surg. 1980; 15: 872-5.
• 11.Pars H, Çavuşoğlu H. A Literature Review ofPercutaneous Endoscopic Gastrostomy: DealingWith Complications. Gastroenterol Nurs. 2019; 42:351-9.
• 12.Stenberg K, Eriksson A, Odensten C, Darehed D.Mortality and complications after percutaneousendoscopic gastrostomy: a retrospectivemulticentre study. BMC Gastroenterol. 2022; 22:361.
• 13.Traunero A, Baldo F, Magnolato A, et al.Administration of bicarbonates throughpercutaneous gastrostomy with continuousnocturnal infusion in a patient with Kearns-Sayredisease: a life changing therapeutical paradigm. ItalJ Pediatr. 2024; 50: 132.
• 14.Schrag SP, Sharma R, Jaik NP, et al. Complicationsrelated to percutaneous endoscopic gastrostomy(PEG) tubes. A comprehensive clinical review. JGastrointestin Liver Dis. 2007; 16: 407–18.
• 15.Geerse DA, Bindels AJ, Kuiper MA, et al.Treatment of hypophosphatemia in the intensivecare unit: a review. Crit Care. 2010; 14: R147.
• 16.Tani M, Morimatsu H, Takatsu F, Morita K. Theincidence and prognostic value of hypochloremia incritically ill patients. ScientificWorldJournal. 2012;2012: 474185.
• 17.Muratori R, Lisotti A, Fusaroli P, et al. Severehypernatremia as a predictor of mortality afterpercutaneous endoscopic gastrostomy (PEG)placement. Dig Liver Dis. 2017; 49: 181-7.
• 18.Buffington MA, Abreo K. Hyponatremia: AReview. J Intensive Care Med. 2016; 31: 223-36.
• 19.Cúrdia GT, Marinho C, Magalhães J, et al.Percutaneous endoscopic gastrostomy: confirmingthe clinical benefits far beyond anthropometry. EurJ Gastroenterol Hepatol. 2017; 29: 1097-101.
• 20.Du G, Liu F, Ma X, et al. Comparison BetweenPercutaneous Endoscopic Gastrostomy andNasogastric Feeding in 160 Patients withSwallowing Disturbances: A Two-Year Follow-UpStudy. Clin Interv Aging. 2022; 17: 1803-10.